Propionate and bone health

  • Research type

    Research Study

  • Full title

    Increasing gut-derived propionate to improve bone health in postmenopausal women

  • IRAS ID

    307502

  • Contact name

    Edward Chambers

  • Contact email

    e.chambers@imperial.ac.uk

  • Sponsor organisation

    Imperial College London and Imperial College Healthcare NHS Trust

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    There are >500,000 osteoporotic fractures per year in the UK, which causes considerable individual suffering and costs the NHS £4.4bn1. Older women (>50 years) have a 2.5-fold increased risk of osteoporotic fractures compared with older men, owing to the profound impact of the menopause on bone turnover. Pharmacological interventions to improve bone turnover and prevent osteoporotic fractures are limited by the cost and adverse side effects of approved drugs. Consequently, there is an urgent need for effective, safe, inexpensive, and widely applicable interventions to prevent osteoporotic fractures in postmenopausal women.

    Higher intakes of dietary fibre in postmenopausal women improve bone mineral density (BMD), an important risk determinant for osteoporotic fractures. Investigations highlight that the short chain fatty acid (SCFA) propionate, generated from gut bacterial fermentation of dietary fibre, improves bone turnover and mass. Accordingly, interventions that can augment gut-derived propionate in postmenopausal women may be an effective strategy at improving bone turnover and preventing osteoporotic fractures.

    To selectively raise gut-derived propionate we have developed an inulin-propionate ester (IPE). We estimate that the addition of 10 g IPE to the diet of a typical UK adult leads to a 2.5-fold increase in daily propionate production. The IPE is a food supplement produced by Dr Douglas Morrison at The University of Glasgow.

    The primary objective of this project is to develop in vivo proof-of-concept for IPE to improve bone turnover markers in postmenopausal women.

  • REC name

    London - South East Research Ethics Committee

  • REC reference

    21/LO/0913

  • Date of REC Opinion

    14 Dec 2021

  • REC opinion

    Favourable Opinion